How Institutional Funds Moved on GERN

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
Deep Track Capital, LP Deep Track Capital, LP exited a position previously worth $47,263,214. 2026-06-30
RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P. reduced this position by 42% ($95,019,335 -> $54,796,481). 2026-06-30
Point72 Asset Management, L.P. Point72 Asset Management, L.P. reduced this position by 83% ($30,481,130 -> $5,177,857). 2026-06-30
RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC increased this position by 119% ($2,681,286 -> $5,861,120). 2026-06-30
Soleus Capital Management, L.P. Soleus Capital Management, L.P. reduced this position by 11% ($61,847,902 -> $54,795,084). 2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC VANGUARD PORTFOLIO MANAGEMENT LLC increased this position by 99% ($6,956,487 -> $13,840,125). 2026-06-30
SEGALL BRYANT & HAMILL, LLC SEGALL BRYANT & HAMILL, LLC opened a new position worth $5,741,509. 2026-06-30
Sixth Street Partners Management Company, L.P. Sixth Street Partners Management Company, L.P. opened a new position worth $5,484,367. 2026-06-30

Which Funds Hold GERN

Largest reported positions as of 2026-06-30.

FundValueShares
RA CAPITAL MANAGEMENT, L.P. $54,796,481 42,809,751
Soleus Capital Management, L.P. $54,795,084 42,808,659
VANGUARD CAPITAL MANAGEMENT LLC $34,880,275 27,250,215
CITADEL ADVISORS LLC $29,706,728 23,208,381
Clearbridge Investments, LLC $25,150,531 19,648,853
Eversept Partners, LP $23,958,300 18,717,422
GOLDMAN SACHS GROUP INC $20,398,367 15,936,224
GEODE CAPITAL MANAGEMENT, LLC $16,055,546 12,540,400
Nantahala Capital Management, LLC $15,648,000 12,225,000
VANGUARD PORTFOLIO MANAGEMENT LLC $13,840,125 10,812,598

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Soleus Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly

Chart-style summary of Soleus Capital Management, L.P.'s 13F portfolio changes for the quarter ending 2026-03-31, showing new positions, increases, and exits across healthcare and biotech stocks.

Soleus Capital Management, L.P. is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This profile tracks those disclosures over time, giving a running record of the fund’s reported buys, sells, and position size changes as new 13F data becomes available. Because 13F filings only capture a quarterly … Read more